Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide

Angiotensin-Converting Enzyme N-Terminal Inactivation Alleviates Bleomycin-Induced Lung Injury

(2010) Ping Li et al.   AMERICAN JOURNAL OF PATHOLOGY

Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril

(2010) Jean M. Watermeyer et al.   BIOCHEMICAL JOURNAL

The N Domain of Human Angiotensin-I-converting Enzyme

(2010) Colin S. Anthony et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mast cell chymase limits the cardiac efficacy of Ang I–converting enzyme inhibitor therapy in rodents

(2010) Chih-Chang Wei et al.   JOURNAL OF CLINICAL INVESTIGATION

Inhibition of Zinc Metallopeptidases in Cardiovascular Disease - From Unity to Trinity, or Duality?

(2009) Vincent Dive et al.   CURRENT PHARMACEUTICAL DESIGN

Phosphinic Tripeptides as Dual Angiotensin-Converting Enzyme C-Domain and Endothelin-Converting Enzyme-1 Inhibitors

(2009) Nicolas Jullien et al.   JOURNAL OF MEDICINAL CHEMISTRY

Probing the Basis of Domain-Dependent Inhibition Using Novel Ketone Inhibitors of Angiotensin-Converting Enzyme†‡

(2008) Jean M. Watermeyer et al.   BIOCHEMISTRY

Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo

(2007) Sebastien Fuchs et al.   HYPERTENSION